US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD

4.90

-0.1000-2.00%

Post-market: 4.900.00000.00%16:36 EST

Volume:37.47K

Turnover:184.18K

Market Cap:57.89M

PE:-1.35

High:4.97

Open:4.87

Low:4.84

Close:5.00

52wk High:16.25

52wk Low:3.50

Shares:11.81M

Float Shares:5.05M

Volume Ratio:0.57

T/O Rate:0.74%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.6237

EPS(LYR):-3.6237

ROE:-109.20%

ROA:-27.70%

PB:1.83

PE(LYR):-1.35

Loading ...

Overview Company News Filings

Analysts Conflicted on These Healthcare Names: Resmed (RMD), Radiopharm Theranostics Limited Sponsored ADR (RADX) and Stryker (SYK)

Radiopharm Theranostics Says Cash And Cash Equivalents Of Approximately $34.52m For Or The 6 Months Ended December 31, 2025 Provide Runway Into 2027

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Top Premarket Decliners

MT Newswires Live

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Benzinga_recent_news

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM

Top Premarket Gainers

MT Newswires Live

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM

Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer

Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases

Radiopharm starts enrollment of third cohort in Phase 1 trial of 177Lu-RAD204

Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204

Analysts’ Top Healthcare Picks: Tango Therapeutics (TNGX), Radiopharm Theranostics Limited Sponsored ADR (RADX)

Radiopharm Theranostics Expects to Raise $22.7 Million Via Private Placement, Shares Down Pre-Bell

MT Newswires Live

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

Radiopharm launches A$5M share purchase plan

Radiopharm Theranostics trading resumes

Radiopharm receives DSMC recommendation to advance Phase 1 ‘HEAT’ trial

Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RADX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RADX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RADX\",,,,,undefined,":{"symbol":"RADX","market":"US","secType":"STK","nameCN":"RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD","latestPrice":4.9,"timestamp":1771016400000,"preClose":5,"halted":0,"volume":37472,"hourTrading":{"tag":"盘后","latestPrice":4.9,"preClose":4.9,"latestTime":"16:36 EST","volume":3,"amount":14.7999,"timestamp":1771018582786,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.019999999999999928,"floatShares":5053900,"shares":11814053,"eps":-3.623681,"marketStatus":"Closed President's Day","change":-0.1,"latestTime":"02-13 16:00:00 EST","open":4.87,"high":4.97,"low":4.84,"amount":184178.926976,"amplitude":0.026,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.623681,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"adrRate":300,"exchange":"NASDAQ","adjPreClose":5,"preHourTrading":{"tag":"盘前","latestPrice":4.85,"preClose":5,"latestTime":"09:29 EST","volume":112,"amount":544.988864,"timestamp":1770992999999,"change":-0.15,"changeRate":-0.03,"amplitude":0.02998},"postHourTrading":{"tag":"盘后","latestPrice":4.9,"preClose":4.9,"latestTime":"16:36 EST","volume":3,"amount":14.7999,"timestamp":1771018582786,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5678264045771038},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RADX\",,,,,undefined,":{"symbol":"RADX","floatShares":5053900,"roa":"-27.70%","roe":"-109.20%","lyrEps":-3.623681,"volumeRatio":0.5678264045771038,"shares":11814053,"dividePrice":0,"high":4.97,"amplitude":0.026,"preClose":5,"low":4.84,"week52Low":3.4962,"pbRate":"1.83","psRate":"6.54","week52High":16.25,"institutionHeld":0,"latestPrice":4.9,"eps":-3.623681,"divideRate":0,"volume":37472,"delay":0,"ttmEps":-3.623681,"open":4.87,"prevYearClose":5.22,"prevWeekClose":4.9,"prevMonthClose":5.05,"prevQuarterClose":5.22,"fiveDayClose":4.97,"twentyDayClose":5.15,"sixtyDayClose":4.515},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RADX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RADX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RADX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1753765200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RADX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RADX","date":"2026-02-13","current":-1.352216,"percent":0.102326,"low":-2.495767,"twenty":-1.667996,"median":-1.314224,"eighty":-1.139778,"high":-0.271806,"avg":-1.36991,"sd":0.449355,"marketCap":55307671.3},"quantilePoints":[{"date":"2024-05-31","current":-0.322141,"twenty":-0.346302,"median":-0.337241,"eighty":-0.328181,"marketCap":9781385.7},{"date":"2024-06-07","current":-0.281873,"twenty":-0.336235,"median":-0.302007,"eighty":-0.293953,"marketCap":8486028.31},{"date":"2024-06-14","current":-0.302007,"twenty":-0.326168,"median":-0.302007,"eighty":-0.293953,"marketCap":9131850.7},{"date":"2024-06-21","current":-0.342275,"twenty":-0.338248,"median":-0.302007,"eighty":-0.302007,"marketCap":10381004.78},{"date":"2024-06-28","current":-0.382542,"twenty":-0.348315,"median":-0.302007,"eighty":-0.302007,"marketCap":11671968.91},{"date":"2024-07-05","current":-0.809355,"twenty":-0.41073,"median":-0.332208,"eighty":-0.302007,"marketCap":24962852.9},{"date":"2024-07-12","current":-0.855604,"twenty":-0.818605,"median":-0.342275,"eighty":-0.302007,"marketCap":26579320.02},{"date":"2024-07-19","current":-0.855604,"twenty":-0.850979,"median":-0.352342,"eighty":-0.302007,"marketCap":26173936.05},{"date":"2024-07-26","current":-0.809355,"twenty":-0.855604,"median":-0.40771,"eighty":-0.302007,"marketCap":24246591.55},{"date":"2024-08-02","current":-0.809355,"twenty":-0.855604,"median":-0.809355,"eighty":-0.302007,"marketCap":24110756.3},{"date":"2024-08-09","current":-0.739982,"twenty":-0.850979,"median":-0.751544,"eighty":-0.302007,"marketCap":22251399.26},{"date":"2024-08-16","current":-0.855604,"twenty":-0.850979,"median":-0.763106,"eighty":-0.306034,"marketCap":25968950.02},{"date":"2024-08-23","current":-1.545856,"twenty":-0.855604,"median":-0.809355,"eighty":-0.324154,"marketCap":47995902.64},{"date":"2024-08-30","current":-1.604426,"twenty":-0.878729,"median":-0.809355,"eighty":-0.334221,"marketCap":52075270.43},{"date":"2024-09-06","current":-1.387611,"twenty":-0.878729,"median":-0.809355,"eighty":-0.342275,"marketCap":44469151.18},{"date":"2024-09-13","current":-1.359542,"twenty":-1.344249,"median":-0.809355,"eighty":-0.342275,"marketCap":43759697.93},{"date":"2024-09-20","current":-1.450178,"twenty":-1.387611,"median":-0.820917,"eighty":-0.342275,"marketCap":47180583.53},{"date":"2024-09-27","current":-1.359542,"twenty":-1.40486,"median":-0.83248,"eighty":-0.342275,"marketCap":45125863.21},{"date":"2024-10-04","current":-1.223587,"twenty":-1.40486,"median":-0.855604,"eighty":-0.352342,"marketCap":39830237.61},{"date":"2024-10-11","current":-1.223587,"twenty":-1.387611,"median":-0.855604,"eighty":-0.382542,"marketCap":39633817.47},{"date":"2024-10-18","current":-1.268906,"twenty":-1.387611,"median":-0.878729,"eighty":-0.402676,"marketCap":40804037.96},{"date":"2024-10-25","current":-1.178269,"twenty":-1.359542,"median":-0.878729,"eighty":-0.412743,"marketCap":37457388.45},{"date":"2024-11-01","current":-1.087633,"twenty":-1.359542,"median":-0.878729,"eighty":-0.463078,"marketCap":34300880.03},{"date":"2024-11-08","current":-1.087633,"twenty":-1.359542,"median":-0.960522,"eighty":-0.693733,"marketCap":34332493.75},{"date":"2024-11-15","current":-1.132951,"twenty":-1.359542,"median":-1.087633,"eighty":-0.705295,"marketCap":35106642.11},{"date":"2024-11-22","current":-1.132951,"twenty":-1.344249,"median":-1.087633,"eighty":-0.739982,"marketCap":35229583.66},{"date":"2024-11-29","current":-1.268906,"twenty":-1.347308,"median":-1.098963,"eighty":-0.739982,"marketCap":39624162.16},{"date":"2024-12-06","current":-1.40486,"twenty":-1.347308,"median":-1.132951,"eighty":-0.739982,"marketCap":43039922.69},{"date":"2024-12-13","current":-1.314224,"twenty":-1.359542,"median":-1.178269,"eighty":-0.758481,"marketCap":40045666.62},{"date":"2024-12-20","current":-1.097941,"twenty":-1.359542,"median":-1.178269,"eighty":-0.781606,"marketCap":32921846.04},{"date":"2024-12-27","current":-1.052194,"twenty":-1.350366,"median":-1.132951,"eighty":-0.800105,"marketCap":31363775.33},{"date":"2025-01-03","current":-1.143689,"twenty":-1.332239,"median":-1.132951,"eighty":-0.809355,"marketCap":34031822.64},{"date":"2025-01-10","current":-1.69849,"twenty":-1.338244,"median":-1.132951,"eighty":-0.809355,"marketCap":50037538.71},{"date":"2025-01-17","current":-1.358792,"twenty":-1.359542,"median":-1.13832,"eighty":-0.809355,"marketCap":40487744.22},{"date":"2025-01-24","current":-1.314257,"twenty":-1.359542,"median":-1.160979,"eighty":-0.809355,"marketCap":39844121.78},{"date":"2025-01-31","current":-1.216905,"twenty":-1.358792,"median":-1.178269,"eighty":-0.809355,"marketCap":36388838.79},{"date":"2025-02-07","current":-1.216905,"twenty":-1.358792,"median":-1.178269,"eighty":-0.809355,"marketCap":36546099.84},{"date":"2025-02-14","current":-1.216905,"twenty":-1.344249,"median":-1.178269,"eighty":-0.809355,"marketCap":37113282.66},{"date":"2025-02-21","current":-1.168228,"twenty":-1.320255,"median":-1.178269,"eighty":-0.809355,"marketCap":35712797.58},{"date":"2025-02-28","current":-1.411154,"twenty":-1.320255,"median":-1.178269,"eighty":-0.809355,"marketCap":37675223.82},{"date":"2025-03-07","current":-1.628255,"twenty":-1.359542,"median":-1.178269,"eighty":-0.809355,"marketCap":44128949.39},{"date":"2025-03-14","current":-1.519704,"twenty":-1.365156,"median":-1.178269,"eighty":-0.818605,"marketCap":41272857.77},{"date":"2025-03-21","current":-1.519704,"twenty":-1.40486,"median":-1.200928,"eighty":-0.830167,"marketCap":40977829.82},{"date":"2025-03-28","current":-1.519704,"twenty":-1.408087,"median":-1.216905,"eighty":-0.83248,"marketCap":41148119.25},{"date":"2025-04-04","current":-1.248329,"twenty":-1.408087,"median":-1.216905,"eighty":-0.83248,"marketCap":32359722.11},{"date":"2025-04-11","current":-1.248329,"twenty":-1.405352,"median":-1.216905,"eighty":-0.83248,"marketCap":33413135.19},{"date":"2025-04-17","current":-1.194053,"twenty":-1.40486,"median":-1.216905,"eighty":-0.846354,"marketCap":32759705.88},{"date":"2025-04-25","current":-1.139778,"twenty":-1.40486,"median":-1.216905,"eighty":-0.855604,"marketCap":31306580.22},{"date":"2025-05-02","current":-1.248329,"twenty":-1.40486,"median":-1.208916,"eighty":-0.855604,"marketCap":34593080.94},{"date":"2025-05-09","current":-1.166916,"twenty":-1.40486,"median":-1.194053,"eighty":-0.855604,"marketCap":32202126.03},{"date":"2025-05-16","current":-1.194053,"twenty":-1.394511,"median":-1.194053,"eighty":-0.855604,"marketCap":32809944.41},{"date":"2025-05-23","current":-1.139778,"twenty":-1.387611,"median":-1.194053,"eighty":-0.869479,"marketCap":31441132.85},{"date":"2025-05-30","current":-1.302604,"twenty":-1.376383,"median":-1.194053,"eighty":-0.878729,"marketCap":36099454.15},{"date":"2025-06-06","current":-1.356879,"twenty":-1.40486,"median":-1.194053,"eighty":-0.878729,"marketCap":38067264.48},{"date":"2025-06-13","current":-1.411154,"twenty":-1.40486,"median":-1.216905,"eighty":-0.878729,"marketCap":39569302.95},{"date":"2025-06-20","current":-1.302604,"twenty":-1.40486,"median":-1.216905,"eighty":-0.878729,"marketCap":36150708.62},{"date":"2025-06-27","current":-1.209897,"twenty":-1.40486,"median":-1.216905,"eighty":-0.878729,"marketCap":34052548.6},{"date":"2025-07-03","current":-1.209897,"twenty":-1.40486,"median":-1.216905,"eighty":-0.878729,"marketCap":34189045.21},{"date":"2025-07-11","current":-1.209897,"twenty":-1.40486,"median":-1.216905,"eighty":-0.878729,"marketCap":34148653.85},{"date":"2025-07-18","current":-1.209897,"twenty":-1.387611,"median":-1.209897,"eighty":-0.878729,"marketCap":33730235.98},{"date":"2025-07-25","current":-1.264893,"twenty":-1.387611,"median":-1.209897,"eighty":-0.960699,"marketCap":35934358.2},{"date":"2025-08-01","current":-1.264893,"twenty":-1.359542,"median":-1.209897,"eighty":-1.031228,"marketCap":34977710.76},{"date":"2025-08-08","current":-1.319888,"twenty":-1.359542,"median":-1.216905,"eighty":-1.042315,"marketCap":36889892.11},{"date":"2025-08-15","current":-1.429879,"twenty":-1.374883,"median":-1.216905,"eighty":-1.045717,"marketCap":39922534.09},{"date":"2025-08-22","current":-1.484874,"twenty":-1.387611,"median":-1.216905,"eighty":-1.052194,"marketCap":41008050.86},{"date":"2025-08-29","current":-1.539869,"twenty":-1.40486,"median":-1.216905,"eighty":-1.052194,"marketCap":43209517.78},{"date":"2025-09-05","current":-1.804169,"twenty":-1.411154,"median":-1.219048,"eighty":-1.052194,"marketCap":43085813},{"date":"2025-09-12","current":-1.997473,"twenty":-1.411154,"median":-1.223587,"eighty":-1.052194,"marketCap":48781312.13},{"date":"2025-09-19","current":-1.997473,"twenty":-1.411626,"median":-1.223587,"eighty":-1.078841,"marketCap":48506969.7},{"date":"2025-09-26","current":-1.78871,"twenty":-1.434815,"median":-1.223587,"eighty":-1.087207,"marketCap":44899204.58},{"date":"2025-10-03","current":-2.035429,"twenty":-1.465429,"median":-1.242862,"eighty":-1.087633,"marketCap":51388248.5},{"date":"2025-10-10","current":-2.282147,"twenty":-1.474337,"median":-1.248329,"eighty":-1.087633,"marketCap":57333987.03},{"date":"2025-10-17","current":-2.282147,"twenty":-1.484874,"median":-1.248329,"eighty":-1.087633,"marketCap":56871916.68},{"date":"2025-10-24","current":-1.603671,"twenty":-1.496475,"median":-1.264893,"eighty":-1.087633,"marketCap":40034303.67},{"date":"2025-10-31","current":-1.480312,"twenty":-1.496475,"median":-1.264893,"eighty":-1.087633,"marketCap":37196925.09},{"date":"2025-11-07","current":-1.667996,"twenty":-1.508839,"median":-1.264893,"eighty":-1.095879,"marketCap":41344030},{"date":"2025-11-14","current":-1.595475,"twenty":-1.519704,"median":-1.265237,"eighty":-1.097941,"marketCap":40095972.34},{"date":"2025-11-21","current":-1.559214,"twenty":-1.526336,"median":-1.265581,"eighty":-1.097941,"marketCap":38670179.17},{"date":"2025-11-28","current":-1.595475,"twenty":-1.539869,"median":-1.265581,"eighty":-1.097941,"marketCap":39962388.95},{"date":"2025-12-05","current":-1.595475,"twenty":-1.541991,"median":-1.268906,"eighty":-1.097941,"marketCap":40496772.81},{"date":"2025-12-12","current":-1.384154,"twenty":-1.541285,"median":-1.268906,"eighty":-1.097941,"marketCap":35376521.13},{"date":"2025-12-19","current":-1.894105,"twenty":-1.545856,"median":-1.268906,"eighty":-1.105352,"marketCap":48095792.72},{"date":"2025-12-26","current":-2.495767,"twenty":-1.55669,"median":-1.268906,"eighty":-1.119356,"marketCap":64120769.23},{"date":"2026-01-02","current":-2.310895,"twenty":-1.583702,"median":-1.268906,"eighty":-1.132951,"marketCap":59121507.97},{"date":"2026-01-09","current":-2.310895,"twenty":-1.595475,"median":-1.268906,"eighty":-1.132951,"marketCap":59271793.43},{"date":"2026-01-16","current":-2.310895,"twenty":-1.602032,"median":-1.274055,"eighty":-1.134316,"marketCap":59450754.16},{"date":"2026-01-23","current":-2.126024,"twenty":-1.604426,"median":-1.301745,"eighty":-1.139778,"marketCap":55715242.29},{"date":"2026-01-30","current":-1.941152,"twenty":-1.628255,"median":-1.302604,"eighty":-1.139778,"marketCap":52080707.44},{"date":"2026-02-06","current":-1.941152,"twenty":-1.667996,"median":-1.306954,"eighty":-1.139778,"marketCap":51841289.27},{"date":"2026-02-13","current":-2.033588,"twenty":-1.667996,"median":-1.314224,"eighty":-1.139778,"marketCap":55307671.3}],"updateTime":1771235585258},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RADX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607042508","title":"Analysts Conflicted on These Healthcare Names: Resmed (RMD), Radiopharm Theranostics Limited Sponsored ADR (RADX) and Stryker (SYK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2607042508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607042508?lang=en_us&edition=fundamental","pubTime":"2026-01-30 23:10","pubTimestamp":1769785819,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Resmed (RMD – Research Report), Radiopharm Theranostics Limited S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-resmed-rmd-radiopharm-theranostics-limited-sponsored-adr-radx-and-stryker-syk-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-resmed-rmd-radiopharm-theranostics-limited-sponsored-adr-radx-and-stryker-syk-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0882574055.USD","LU1791710400.SGD","LU0114720955.EUR","BK4566","LU0289739699.SGD","HCSG","LU1983299246.USD","LU2324357040.USD","LU2362540622.SGD","LU2404859667.USD","XBI","XLV","LU2404859741.USD","LU1791710582.SGD","LU0690374615.EUR","BK4137","LU0029874061.USD","LU2362541513.USD","SYK","BK4581","GB00B4QBRK32.GBP","BK4504","BK4588","BK4082","LU0058720904.USD","LU2468319806.SGD","LU2362541273.HKD","BK4139","LU0690374961.EUR","GB00B4LPDJ14.GBP","LABU","BK4585","RADX","LU0528227936.USD","LU0432979614.USD","LU0128526141.USD","LU2089984988.USD"],"gpt_icon":0},{"id":"2606151727","title":"Radiopharm Theranostics Says Cash And Cash Equivalents Of Approximately $34.52m For Or The 6 Months Ended December 31, 2025 Provide Runway Into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2606151727","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606151727?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:09","pubTimestamp":1769602148,"startTime":"0","endTime":"0","summary":"Program and Business Updates18F-RAD101 – Small molecule targeting fatty acid synthase radiolabeled with Fluorine-18RAD 101 is being evaluated in a single-arm U.S. Phase 2b clinical trial for the diagnostic performance of","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/01/50184651/radiopharm-theranostics-says-cash-and-cash-equivalents-of-approximately-34-52m-for-or-the-6-months-","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4213","BK4183","BK4139","DSMC","SOC","ODD","RADX"],"gpt_icon":0},{"id":"2602140175","title":"RAD Increases Ownership in Radiopharm Ventures to 87.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602140175","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602140175?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:00","pubTimestamp":1768219200,"startTime":"0","endTime":"0","summary":"Radiopharm Ventures, LLC, is a joint venture created in 2022 between MD Anderson Cancer Center and Radiopharm TheranosticsLeading candidate Betabart, a monoclonal antibody targeting B7H3, has received","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/12/3216685/0/en/RAD-Increases-Ownership-in-Radiopharm-Ventures-to-87-5.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RADX","BK4128","RAD","BK4139"],"gpt_icon":0},{"id":"2591846029","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2591846029","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591846029?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:50","pubTimestamp":1765889424,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics  shares were 39% lower pre-bell Tuesday, paring Monday's rally.Lightwave Logic  stock was down 19% after the company said late Monday it priced an underwritten offering of 11.7 million common shares for gross proceeds of about $35 million.Ascent Solar Technologies  shares were 13% lower, shaving gains from the previous session.Verrica Pharmaceuticals  stock was down 12%, adding to losses from the previous session.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","VRCA","BK4141","RADX","LWLG","BK4148","BK4139","ASTI"],"gpt_icon":0},{"id":"2591162580","title":"Why Is Radiopharm Theranostics Stock Rallying Over 140%?","url":"https://stock-news.laohu8.com/highlight/detail?id=2591162580","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591162580?lang=en_us&edition=fundamental","pubTime":"2025-12-16 00:59","pubTimestamp":1765817940,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics shares rise after interim Phase 2b data showed 92% MRI concordance for RAD 101 imaging in brain metastases.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/15/Medical-Research-And-Development-Center-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/15/Medical-Research-And-Development-Center-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/12/49398862/why-is-radiopharm-theranostics-stock-rallying-over-140","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49398862/why-is-radiopharm-theranostics-stock-rallying-over-140","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["RADX","BK4139"],"gpt_icon":0},{"id":"2591429406","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:34 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2591429406","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591429406?lang=en_us&edition=fundamental","pubTime":"2025-12-15 22:34","pubTimestamp":1765809291,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:34 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nAQN2LDLJR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RADX","BK4139"],"gpt_icon":0},{"id":"2591264617","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2591264617","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591264617?lang=en_us&edition=fundamental","pubTime":"2025-12-15 20:39","pubTimestamp":1765802365,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics (RADX) shares were nearly 300% higher pre-bell Monday after the company said that RAD 101 achieved the primary endpoint in 92% of patients in a phase 2b trial in brain metastas","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDRX","BK4563","ARBB","IMNM","BK4139","BK4134","RADX"],"gpt_icon":0},{"id":"2591064579","title":"Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2591064579","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591064579?lang=en_us&edition=fundamental","pubTime":"2025-12-15 20:00","pubTimestamp":1765800000,"startTime":"0","endTime":"0","summary":"92% of evaluable patients at interim analysis treated with RAD 101 achieved concordance with MRI imaging (the primary endpoint) with significant and selective tumor uptake in suspected or recurrent br","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/15/3205269/0/en/Radiopharm-Theranostics-Achieves-Primary-Endpoint-in-92-of-Patients-at-Interim-Analysis-of-RAD-101-Phase-2b-Imaging-Trial-in-Brain-Metastases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRS","RAD","RADX","BK4128","BK4139"],"gpt_icon":0},{"id":"2585544491","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 02:06 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2585544491","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585544491?lang=en_us&edition=fundamental","pubTime":"2025-11-21 03:06","pubTimestamp":1763665561,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 02:06 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nAQN2L9MV9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RADX","BK4139"],"gpt_icon":0},{"id":"2584095850","title":"Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584095850","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584095850?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:30","pubTimestamp":1763472600,"startTime":"0","endTime":"0","summary":"RAD 402 is a humanized IgG1 internalized by prostate cells, binding KLK3 with high affinity Tb-161 antitumor activity driven by the dual emission of beta particles and Auger electrons  SYDNEY, Nov.  1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/18/3190037/0/en/Radiopharm-Theranostics-Receives-Approval-to-Initiate-Phase-1-Therapeutic-Trial-of-RAD-402-KLK3-mAb-with-Tb161-in-Advanced-Prostate-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4128","PSA","RAD","BK4585","BK4084","BK4588","BK4217","RADX","BK4139"],"gpt_icon":0},{"id":"2584251126","title":"Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2584251126","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584251126?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:00","pubTimestamp":1763384400,"startTime":"0","endTime":"0","summary":"Early patient data from Phase 2b clinical trial showed significant and selective tumor uptake in brain metastases compared to MRI Phase 2b clinical trial expected to complete enrollment and have topli","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/17/3189074/0/en/Radiopharm-Theranostics-Announces-50-Enrollment-in-Phase-2b-Clinical-Trial-of-RAD101-Imaging-in-Brain-Metastases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","SRS","BK4139","RAD","RADX"],"gpt_icon":0},{"id":"2582741863","title":"Radiopharm starts enrollment of third cohort in Phase 1 trial of 177Lu-RAD204","url":"https://stock-news.laohu8.com/highlight/detail?id=2582741863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582741863?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:35","pubTimestamp":1762954522,"startTime":"0","endTime":"0","summary":"Radiopharm (RADX) Theranostics announced the completion of enrollment for the second cohort of patients in the Phase 1 dose escalation trial of 177...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/radiopharm-starts-enrollment-of-third-cohort-in-phase-1-trial-of-177lu-rad204-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/radiopharm-starts-enrollment-of-third-cohort-in-phase-1-trial-of-177lu-rad204-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RADX","BK4139"],"gpt_icon":0},{"id":"2582722313","title":"Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204","url":"https://stock-news.laohu8.com/highlight/detail?id=2582722313","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582722313?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:30","pubTimestamp":1762954200,"startTime":"0","endTime":"0","summary":"Data Safety Monitoring Committee approves advancing to a higher dose of90mCi The first two Cohorts’ patients show tumor uptake and a favourable safety profile SYDNEY, Nov.  12, 2025  (GLOBE NEWSWIRE) ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/12/3186280/0/en/Radiopharm-Theranostics-starts-enrollment-of-the-Third-Cohort-of-Phase-1-Dose-Escalation-Clinical-Trial-of-177Lu-RAD204.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RADX","BK4139","RAD","BK4128"],"gpt_icon":0},{"id":"2578289686","title":"Analysts’ Top Healthcare Picks: Tango Therapeutics (TNGX), Radiopharm Theranostics Limited Sponsored ADR (RADX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2578289686","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578289686?lang=en_us&edition=fundamental","pubTime":"2025-10-27 22:50","pubTimestamp":1761576614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Tango Therapeutics (TNGX – Research Report), Radioph...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-tango-therapeutics-tngx-radiopharm-theranostics-limited-sponsored-adr-radx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-tango-therapeutics-tngx-radiopharm-theranostics-limited-sponsored-adr-radx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","XBI","BK4588","LU0128526141.USD","LU0029874061.USD","BK4139","BK4581","BK4137","LABU","HCSG","TNGX","BK4585","RADX"],"gpt_icon":0},{"id":"2576851623","title":"Radiopharm Theranostics Expects to Raise $22.7 Million Via Private Placement, Shares Down Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2576851623","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576851623?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:23","pubTimestamp":1760963031,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics  shares were down over 15% in recent Monday premarket activity after the company said it has received firm commitments to raise about 35 million Australian dollars  through an institutional private placement.The company said it will offer shares at AU$0.03 per share, representing a discount of 18.9% to the stock's last close of AU$0.037 on Oct. 15.Lantheus will invest AU$7.6 million under the placement, thereby increasing its stake in the company to 14.5%, Radiopharm said.The company said it has also launched a share purchase plan for existing eligible shareholders in Australia and New Zealand to raise a further AU$5 million. Investors participating in the placement and the share purchase plan will receive one free attaching option for every new share subscribed, which can be exercised at AU$0.039 until Oct. 31, the company said.Radiopharm said that proceeds will be mainly used to fund drug manufacturing, clinical trials, and working capital, extending the fundi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","XJO.AU","RADX","BK4139","XAO.AU"],"gpt_icon":0},{"id":"2576072851","title":"Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2576072851","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576072851?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:00","pubTimestamp":1760961600,"startTime":"0","endTime":"0","summary":"Preliminary data from first three patients in Phase 2b imaging clinical trial of RAD 101 show uptake in brain metastases from solid tumors, confirming proof-of-concept with Phase 2 topline results exp","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/20/3169315/0/en/Radiopharm-Theranostics-Provides-Positive-Clinical-Updates-Across-Four-Programs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD","DSMC","RADX","BK4139","RAD","SOC","BK4183","BK4213","IE0009354923.USD","BK4128"],"gpt_icon":0},{"id":"2576856110","title":"Radiopharm launches A$5M share purchase plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2576856110","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576856110?lang=en_us&edition=fundamental","pubTime":"2025-10-20 19:41","pubTimestamp":1760960467,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics (RADX) received firm commitments from international and Australian institutional and industry investors , including Lantheu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/radiopharm-launches-a5m-share-purchase-plan-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/radiopharm-launches-a5m-share-purchase-plan-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RADX"],"gpt_icon":0},{"id":"2575286493","title":"Radiopharm Theranostics trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2575286493","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575286493?lang=en_us&edition=fundamental","pubTime":"2025-10-14 00:40","pubTimestamp":1760373607,"startTime":"0","endTime":"0","summary":"12:40 EDT Radiopharm (RADX) Theranostics trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/radiopharm-theranostics-trading-resumes-thefly-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/radiopharm-theranostics-trading-resumes-thefly-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RADX","BK4139"],"gpt_icon":0},{"id":"2572399665","title":"Radiopharm receives DSMC recommendation to advance Phase 1 ‘HEAT’ trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2572399665","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572399665?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:15","pubTimestamp":1759320946,"startTime":"0","endTime":"0","summary":"Radiopharm (RADX) Theranostics announced that it has received a positive recommendation from the Data Safety and Monitoring Committee to advance it...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/radiopharm-receives-dsmc-recommendation-to-advance-phase-1-heat-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/radiopharm-receives-dsmc-recommendation-to-advance-phase-1-heat-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DSMC","BK4139","HEAT","RADX"],"gpt_icon":0},{"id":"2572536060","title":"Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2572536060","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572536060?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:00","pubTimestamp":1759320000,"startTime":"0","endTime":"0","summary":"Phase 1 study to progress to the next dose level of 75mCi in patients with HER2+ advanced solid tumors, instead of the protocol-planned dose of 40mCiSYDNEY, Oct.  01, 2025  (GLOBE NEWSWIRE) -- Radioph","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/01/3159443/0/en/Radiopharm-Theranostics-Receives-Positive-Recommendation-from-Data-Safety-and-Monitoring-Committee-DSMC-to-Accelerate-177Lu-RAD202-Phase-1-HEAT-Dose-Escalation-Clinical-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAQC","RAD","BK4139","RADX","DSMC","BK4128","HEAT"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}